Compare KMX & CAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KMX | CAI |
|---|---|---|
| Founded | 1993 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Retail-Auto Dealers and Gas Stations | Medical Specialities |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.6B | 6.0B |
| IPO Year | 2002 | N/A |
| Metric | KMX | CAI |
|---|---|---|
| Price | $42.06 | $18.39 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 17 | 8 |
| Target Price | ★ $40.33 | $33.63 |
| AVG Volume (30 Days) | ★ 3.2M | 2.2M |
| Earning Date | 03-19-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 6.29 | N/A |
| EPS | ★ 2.46 | N/A |
| Revenue | ★ $26,353,420,000.00 | N/A |
| Revenue This Year | N/A | $83.89 |
| Revenue Next Year | $0.69 | $31.68 |
| P/E Ratio | $17.54 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $30.40 | $17.15 |
| 52 Week High | $84.49 | $42.50 |
| Indicator | KMX | CAI |
|---|---|---|
| Relative Strength Index (RSI) | 44.11 | 28.13 |
| Support Level | $39.80 | N/A |
| Resistance Level | $48.44 | $29.07 |
| Average True Range (ATR) | 2.21 | 1.20 |
| MACD | -0.39 | -0.25 |
| Stochastic Oscillator | 29.59 | 21.37 |
CarMax sells, finances, and services used and new cars through a chain of over 250 used retail stores. It was formed in 1993 as a unit of Circuit City and spun off into an independent company in late 2002. Used-vehicle sales were 83% of fiscal 2025 revenue and wholesale about 17%, with the remaining portion composed of extended service plans and repair. In fiscal 2025, the company retailed and wholesaled 789,050 and 544,312 used vehicles, respectively. CarMax is the largest used-vehicle retailer in the US but still estimates that it had only about 3.7% US market share of vehicles 0-10 years old in calendar 2024. It seeks over 5% share. CarMax is based in Richmond, Virginia.
Caris Life Sciences Inc is a patient-centric, next-generation AI TechBio company. It develop and commercialize solutions to transform healthcare through the use of comprehensive molecular information and artificial intelligence/machine learning algorithms at scale.